Yellow Jersey Therapeutics AG clinical trials

Acquired by Johnson & Johnson, Jul 11, 2024 · source ↗

The registry lists 1 studies whose lead sponsor is Yellow Jersey Therapeutics AG. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 6, 2026.

Before and after it joined Johnson & Johnson

First submitted before Yellow Jersey Therapeutics AG became part of Johnson & Johnson: 1
First submitted after Yellow Jersey Therapeutics AG became part of Johnson & Johnson: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Terminated: 1

Phase

Phase 1: 1

Where

Germany: 1
United States: 1
Canada: 1
Poland: 1

Registry sponsor names on this page

Yellow Jersey Therapeutics AG1 study

Something wrong with this grouping? Tell us on the Johnson & Johnson page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Johnson & Johnson studies →

Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)TerminatedNCT05859724Phase 1
Sponsor listed in the registry: Yellow Jersey Therapeutics AG · First submitted before Yellow Jersey Therapeutics AG became part of Johnson & Johnson